Aug 25, 2023, 18:25
David Steensma: I’m excited to have started this new role as Chief Medical Officer of AjaxTherapeutics.
Quoting David Steensma, former Global Head of Hematology at Novartis Institutes for BioMedical Research (NIBR), on X/Twitter:
“I’m excited to have started this new role as Chief Medical Officer of Ajax Therapeutics, focused on developing new medicines for patients with myeloid neoplasms. It is a terrific team and brilliant group of founders led by Ross Levine.”
For details click here.
Source: David Steensma/Twitter
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 1, 2024, 19:12
Nov 1, 2024, 17:46
Nov 1, 2024, 17:41
Nov 1, 2024, 17:27